Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Abivax SA (NASDAQ : ABVX ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Quote
| Last: | $120.6775 |
|---|---|
| Change Percent: | 0.18% |
| Open: | $121.69 |
| Close: | $120.46 |
| High: | $121.69 |
| Low: | $120.2201 |
| Volume: | 92,583 |
| Last Trade Date Time: | 04/16/2026 09:44:24 am |
Stock Data
| Market Cap: | $9,359,969,582 |
|---|---|
| Float: | 53,161,297 |
| Insiders Ownership: | N/A |
| Institutions: | 64 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.abivax.com |
| Country: | FR |
| City: | Paris |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Abivax SA (NASDAQ: ABVX).
